Comen P3 / P6 Infant Phototherapy Devices

The Comen P3/P6 Infant Phototherapy Devices deliver efficient blue LED jaundice therapy with uniform irradiance, low heat output and flexible positioning, with the P6 offering enhanced intensity and dual-surface capability for severe cases.

Description

Advanced LED phototherapy solutions for safe and effective neonatal jaundice treatment

The Comen P3/P6 Infant Phototherapy Devices are engineered to deliver reliable, clinically effective management of neonatal jaundice through high-intensity blue LED illumination within the therapeutic 430–490 nm wavelength range. The P3 offers a compact, energy-efficient phototherapy solution ideal for bassinets, warmers and incubators, while the P6 expands capability with higher irradiance, adjustable intensity levels and optional dual-surface illumination for more severe hyperbilirubinemia cases. Both systems utilize low-heat LED technology for infant comfort, uniform light distribution for consistent therapy results and long-life LED arrays to reduce maintenance demands. Designed for NICUs, maternity wards and postnatal care units, the P3/P6 integrate flexible positioning options, quiet operation and optimized light-field control to support safe, efficient bilirubin reduction across different care environments.

Key Features & Technical Highlights:
• Therapeutic 430–490 nm LED illumination — accelerates bilirubin breakdown for effective neonatal jaundice treatment
• Low-heat, uniform irradiance design — improves infant comfort and ensures consistent clinical results
• Adjustable light head and flexible mounting options — compatible with incubators, warmers and bassinets
• Long-life LEDs with low power consumption — reduces operational costs and equipment downtime
• High-intensity and optional dual-surface mode (P6) — supports faster treatment of moderate to severe hyperbilirubinemia

Workflow & Clinical Use:
The P3/P6 streamline neonatal care by providing stable, low-heat phototherapy with flexible positioning and adjustable intensity, enabling caregivers to initiate treatment rapidly without disrupting routine infant handling.